INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 79 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $26,306 | +31.6% | 124,968 | 0.0% | 0.00% | – |
| Q1 2023 | $19,995 | -71.2% | 124,968 | 0.0% | 0.00% | – |
| Q4 2022 | $69,357 | -53.5% | 124,968 | 0.0% | 0.00% | – |
| Q3 2022 | $149,000 | +204.1% | 124,968 | +62.3% | 0.00% | – |
| Q2 2022 | $49,000 | -61.4% | 76,991 | -31.1% | 0.00% | – |
| Q1 2022 | $127,000 | -49.6% | 111,783 | 0.0% | 0.00% | – |
| Q4 2021 | $252,000 | -34.2% | 111,783 | -0.3% | 0.00% | – |
| Q3 2021 | $383,000 | -93.3% | 112,100 | -74.8% | 0.00% | -100.0% |
| Q2 2014 | $5,676,000 | +7.2% | 445,500 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $5,297,000 | -11.9% | 445,500 | +2.4% | 0.00% | 0.0% |
| Q4 2013 | $6,010,000 | -9.7% | 435,200 | +14.0% | 0.00% | -25.0% |
| Q3 2013 | $6,659,000 | +41.3% | 381,600 | +31.5% | 0.00% | +33.3% |
| Q2 2013 | $4,714,000 | – | 290,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 15,232,268 | $41,279,000 | 3.63% |
| NORTHPOINTE CAPITAL LLC | 528,739 | $1,433,000 | 0.21% |
| Opaleye Management Inc. | 275,000 | $745,000 | 0.19% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 364,401 | $988,000 | 0.12% |
| EcoR1 Capital, LLC | 462,068 | $1,252,000 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 990,748 | $2,685,000 | 0.08% |
| GSA CAPITAL PARTNERS LLP | 284,354 | $771,000 | 0.04% |
| Fosun International Ltd | 358,859 | $879,000 | 0.04% |
| Clear Harbor Asset Management, LLC | 97,630 | $200,000 | 0.04% |
| 180 WEALTH ADVISORS, LLC | 30,000 | $81,000 | 0.04% |